Avalyn Pharma, AltPep, Viome Life Sciences and Parse Biosciences are among various Seattle startups that secured ample funding in 2023, despite tightening budgets, reduced venture capitalist activity and an evolving economy.
GeekWire’s Seattle and Pacific Northwest startup funding list of 2023 revealed that the region’s funding dropped by nearly two-thirds since 2022. However, companies in the aerospace, biotech and health tech sectors remained strong, receiving substantial funding despite the reductions.